Skip to main content
. 2016 Oct 25;1(3):133–139. doi: 10.1136/svn-2016-000018

Table 1.

Comparison between patients (with stroke) and controls (without stroke) for patients without diabetes: phase I

Variables Patients (with stroke) (n=233) Controls (healthy matches) (n=245) p Value
Age (years) 54.69±1.60 50.33±1.44 0.96
Gender/sex (males) n (%) 133 (57.08) 130 (53.06) 0.31
Gender/sex (females) n (%) 100 (42.91) 115 (46.93)
BSF (mg/dL) 112.43±5.76 98.7±8.98 0.84
HbA1c (%) 5.93±2.97 5.57±1.65 0.03
HDL-C (mg/dL) 43.00±1.95 46.54±2.43 0.02
LDL-C (mg/dL) 96.40±7.96 87.78±9.83 0.07
TGL-C (mg/dL) 221±37.89 176±27.89 0.00
TC (mg/dL) 178.50±27.66 169.76±26.76 0.21
SBP (mm Hg) 147.63±35.64 126.78±23.34 0.04
DBP (mm Hg) 90.56±16.64 81.24±8.90 0.04
BMI (kg/m2) 24.23±2.34 23.95±2.12 0.18
Smoking n (%) 143 (61.37) 52 (21.22) 0.02

Bold indicates significant p Values. Comparison between patients and controls for patients without diabetes: phase I: values are presented as mean±SD.

BMI, body mass index; BSF, blood sugar fasting; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TGL-C, triglyceride cholesterol.